Authors: Patel, Jigna D.; Gandhapudi, Siva; Jones, Julia; O'Carra, Ronan; Woodward, Jerold G.; Mumper, Russell J.

Source: Journal of Biomedical Nanotechnology, Volume 3, Number 1, April 2007 , pp. 97-106(10)

Publisher: American Scientific Publishers

Abstract:

The use of cationic nanoparticles (NPs) for enhancing the delivery of an immunostimulatory adjuvant, CpG ODN, and model antigen, OVA to dendritic cells was investigated in these studies. In vitro studies demonstrated that NPs were taken up efficiently by bone-marrow derived dendritic cells (BMDDCs), with approximately 70% of the NPs found associated with cells over 12 hr. The presence of NPs intracellulary in DCs was confirmed by confocal microscopy. NPs alone did not cause release of IL-12 from BMDDCs; however, CpG-coated NPs (CpG/NPs) resulted in the release of IL-12 and the cytokine levels were greater using the NPs than CpG alone. Adoptive transfer experiments using OT-1 TCR transgenic T cells demonstrated higher proliferation of the OT-1 cells using OVA-coated NPs (OVA/NPs) compared to OVA alone, especially at lower doses of OVA. Taken together, the in vitro and in vivo data suggest that nanoparticles can enhance the uptake of antigen or immunostimulatory adjuvant into antigen presenting cells such as dendritic cells, and facilitate MHC class I restricted antigen presentation to CD8⁺ T cells. Moreover, in vivo immunization studies in BALB/c mice demonstrated that significant enhancements in humoral immune responses to OVA can be obtained using CpG-coated NPs compared to either CpG or NPs alone.

References: 42 references open in new window

Articles that cite this article?

Keywords: OVALBUMIN; NANOPARTICLES; ADJUVANTS; TH1 RESPONSES; CPG; OT-1 CELLS; ANTIGEN PRESENTATION

Document Type: Research article

DOI: http://dx.doi.org/10.1166/jbn.2007.007

Publication date: 2007-04-01

More about this publication?

• Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Technology ,  Biochemistry
• By this author: Patel, Jigna D. ;  Gandhapudi, Siva ;  Jones, Julia ;  O'Carra, Ronan ;  Woodward, Jerold G. ;  Mumper, Russell J.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers